Literature DB >> 7334066

Role of virus strain in conventional and enhanced measles plaque neutralization test.

P Albrecht, K Herrmann, G R Burns.   

Abstract

A low-passage Edmonston strain of measles virus gave on the average four-fold higher antibody titers than two high-passage strains of Edmonston virus when used in a virus plaque neutralization test. Heterologous anti-human immunoglobulin did not affect antibody titers obtained with the low-passage virus but enhanced antibody titers obtained with the high-passage viruses on the average eight-fold. These differences in virus sensitivity to neutralization and neutralization potentiation by anti-immunoglobulin were interpreted as being possibly due to differences in density or accessibility of the functional antigens of measles virus. The conventional plaque neutralization test utilizing the low-passage Edmonston virus was about 10 times more sensitive than the virus CPE-neutralization test, 60 times more sensitive than the measles hemagglutination-inhibition test and 220 times more sensitive than the measles complement-fixation antibody test.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334066     DOI: 10.1016/0166-0934(81)90062-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  42 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

4.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

5.  Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults.

Authors:  Lee E Morris; Roberto Posada; Carole J Hickman; Donald R Latner; Tricia A Singh; Alyssa Rautenberg; Jennifer Jao; William J Bellini; Rhoda Sperling
Journal:  J Pediatric Infect Dis Soc       Date:  2013-09-24       Impact factor: 3.164

6.  Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Authors:  Amando Zuniga; Mathias Liniger; Teldja Neige Azzouz Morin; René R Marty; Marian Wiegand; Orhan Ilter; Sara Weibel; Martin A Billeter; Marlyse C Knuchel; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

7.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

Authors:  K A Weigle; M D Murphy; P A Brunell
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

9.  Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis.

Authors:  P G Auwaerter; H Kaneshima; J M McCune; G Wiegand; D E Griffin
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.